NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 52 filers reported holding NEOS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $245,000 | +118.8% | 93,684 | +37.8% | 0.00% | – |
Q4 2018 | $112,000 | -77.3% | 67,969 | -33.4% | 0.00% | – |
Q3 2018 | $494,000 | +48.3% | 102,038 | +91.4% | 0.00% | – |
Q2 2018 | $333,000 | -27.1% | 53,302 | -3.2% | 0.00% | – |
Q1 2018 | $457,000 | -50.8% | 55,041 | -39.5% | 0.00% | -100.0% |
Q4 2017 | $928,000 | +71.5% | 90,992 | +53.8% | 0.00% | – |
Q3 2017 | $541,000 | +58.2% | 59,156 | +26.3% | 0.00% | – |
Q2 2017 | $342,000 | +6.2% | 46,853 | +4.9% | 0.00% | – |
Q1 2017 | $322,000 | +23.4% | 44,685 | 0.0% | 0.00% | – |
Q4 2016 | $261,000 | -12.1% | 44,685 | -1.1% | 0.00% | – |
Q3 2016 | $297,000 | -29.1% | 45,174 | 0.0% | 0.00% | – |
Q2 2016 | $419,000 | +142.2% | 45,174 | +181.9% | 0.00% | – |
Q1 2016 | $173,000 | -24.5% | 16,023 | 0.0% | 0.00% | – |
Q4 2015 | $229,000 | -32.0% | 16,023 | 0.0% | 0.00% | – |
Q3 2015 | $337,000 | – | 16,023 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DSC Advisors, L.P. | 1,043,770 | $7,620,000 | 2.51% |
Stonepine Capital Management, LLC | 565,100 | $4,125,000 | 2.23% |
DAFNA Capital Management LLC | 209,873 | $1,532,000 | 1.09% |
Ghost Tree Capital, LLC | 500,000 | $3,650,000 | 0.76% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,459,195 | $10,652,000 | 0.57% |
PURA VIDA INVESTMENTS, LLC | 150,000 | $1,095,000 | 0.44% |
J. Goldman & Co LP | 845,000 | $6,169,000 | 0.33% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 191,729 | $1,400,000 | 0.20% |
Opaleye Management Inc. | 50,000 | $365,000 | 0.15% |
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 50,000 | $365,000 | 0.15% |